Article 229-C of the Brazilian IP Law establishes the need of a “prior approval” by the Agência Nacional de Vigilância Sanitária – ANVISA (the Brazilian regulatory agency responsible for the approval of drugs) – for the issuance of a patent in the pharmaceutical area. This requirement was introduced by the Brazilian Law No. 10.196 of […]